Clinical and therapeutic features of myasthenia gravis in adults based on age at onset.
Elena Cortés-VicenteRodrigo Álvarez-VelascoSonia SegoviaCarmen ParadasCarlos CasasnovasAntonio Guerrero-SolaJulio PardoAlba Ramos-FransiTeresa SevillaAdolfo López de MunainMaria Teresa GómezIvonne JericóGerardo Gutiérrez-GutiérrezAna Lara Pelayo-NegroMaría Asunción MartínMaría Dolores MendozaGermán MorísRicard Rojas-GarciaJordi Díaz-ManeraLuis QuerolEduard GallardoBeatriz VélezMaría Antonia AlbertíLucía GalánTania García-SobrinoAlicia Martínez-PiñeiroAna Lozano-VeintimillaRoberto Fernández-TorrónÁngel Cano-AbascalIsabel IllaPublished in: Neurology (2020)
Patients with MG are primarily ≥65 years of age with anti-AChR antibodies and no thymoma. Although patients with very-late-onset MG may present life-threatening events at onset, they achieve a good outcome with fewer immunosuppressants when diagnosed and treated properly.